Suzanne E. Geerlings
About
In The Last Decade
Suzanne E. Geerlings
198 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Epidemiology 5.5k
- Infectious Diseases 1.8k
- Rheumatology 1.8k
- Urology 1.6k
- Pediatrics, Perinatology and Child Health 1.4k
Countries citing papers authored by Suzanne E. Geerlings
This map shows the geographic impact of Suzanne E. Geerlings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne E. Geerlings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne E. Geerlings more than expected).
Fields of papers citing papers by Suzanne E. Geerlings
This network shows the impact of papers produced by Suzanne E. Geerlings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne E. Geerlings. The network helps show where Suzanne E. Geerlings may publish in the future.
Co-authorship network of co-authors of Suzanne E. Geerlings
This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne E. Geerlings. A scholar is included among the top collaborators of Suzanne E. Geerlings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne E. Geerlings. Suzanne E. Geerlings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines breakdown → | 91 |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 10 | |
| 9 | 5 | |
| 10 | 4 | |
| 11 | Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America breakdown → | 284 |
| 12 | [Mapping HIV prevalence in the Netherlands with geographic information systems]. | 6 |
| 13 | 12 | |
| 14 | Hiv-bestrijding begint met GIS-werk | 1 |
| 15 | 10 | |
| 16 | [Appropriate use of antibiotics shortens length of hospital stay]. | 4 |
| 17 | Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double-blind, noninferiority trial in postmenopausal women | 3 |
| 18 | Severe cerebral toxoplasma infection cannot be excluded by a normal CT scan. | 10 |
| 19 | Treatment of Urinary Tract Infections (UTI) in Women with Diabetes Mellitus (DM); Lower Recurrence Rate with Norfloxacin Compared to Nitrofurantoin or Trimethoprim | 0 |
| 20 | Immune dysfunction in patients with diabetes mellitus (DM) breakdown → | 943 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.